Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study.
about
The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular DiseaseThe Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosisSmall G proteins in the cardiovascular system: physiological and pathological aspectsIntegrin-linked kinase is required for radial sorting of axons and Schwann cell remyelination in the peripheral nervous systemLittle ROCK is a ROCK1 pseudogene expressed in human smooth muscle cellsFasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophyNew approaches to the treatment of pulmonary hypertension: from bench to bedside.The role of rho kinase in sex-dependent vascular dysfunction in type 1 diabetes.Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.RhoA/Rho-kinase and vascular diseases: what is the link?Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanismRho-kinase activation in leukocytes plays a pivotal role in myocardial ischemia/reperfusion injury.Multimodal effects of small molecule ROCK and LIMK inhibitors on mitosis, and their implication as anti-leukemia agents.Critical role of exogenous nitric oxide in ROCK activity in vascular smooth muscle cells.Rho kinase as a therapeutic target in cardiovascular disease.Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens.Rho kinase, a promising drug target for neurological disorders.ROCKs as therapeutic targets in cardiovascular diseasesCardiovascular effects of a novel potent and highly selective azaindole-based inhibitor of Rho-kinase.Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges.Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.Physiological role of ROCKs in the cardiovascular systemApplications for ROCK kinase inhibitionThe therapeutic effects of Rho-ROCK inhibitors on CNS disorders.Rho kinase (ROCK) inhibitors.Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus.Inhibition of ROCK activity allows InlF-mediated invasion and increased virulence of Listeria monocytogenes.Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trial.Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffnessRho kinase inhibition improves endothelial function in human subjects with coronary artery disease.Measurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudilSignaling through Rho GTPase pathway as viable drug target.Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosisEvidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension.Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.Emerging medical treatment for angina pectoris.Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases.
P2860
Q26774795-6DAB3FC5-48AF-4482-A4CC-58F04E938464Q27005980-39B44D40-6650-4F0A-B958-0D99D865641CQ27010607-00B81362-1906-4402-8624-3CB5A17471ECQ28587844-E73228FA-5981-432F-B9A9-F619FDC65C46Q28752240-3B7E94A3-7E98-4277-9A18-6EBF5C16A454Q30511954-1D5CD911-7625-417B-BE3A-0C10AD3ED911Q33690368-6256A7B0-A31C-433C-A37C-D7723ADFEC94Q33756580-79CA45C7-1703-4D65-AA69-4F6E4A55F3ABQ34362144-E71EF240-50A0-4C4A-865B-7F1E60A1FCBCQ34378293-13435691-4E7F-40CA-A6B5-661BDFF32B33Q34823543-275E8076-BAB0-46C2-A4D2-E6F5B5957464Q35007551-FFBBD362-6899-414A-BE19-97661AE02A1BQ35123172-25A6A89D-1F39-422F-8C7B-612D2FD314E0Q35123961-15966FE5-6874-474E-9608-D769D8322D21Q35299517-63C42344-DC0F-4B2E-8334-02F9829893F7Q35352722-3CADF143-98A9-4132-9897-D4CDABC1289EQ35756665-D8F27528-4019-4403-9196-7573AB24CA42Q36111908-6D7FBABC-44A0-41EF-AF58-14F95A6DF204Q36124892-58DABB39-75DC-4CC3-88DA-0EFAE839BE30Q36171342-0138B564-1807-42B8-BF54-165366C42B7DQ36219699-80AD3FB4-DD82-49D6-8DF0-2C1962096AB1Q36337932-D862E981-43AA-4AF0-8719-9935A011EA03Q36392528-BB401A63-D7CF-42F0-878E-24D3B635829DQ36649417-B36A5317-D160-42FF-9B3A-377B233DF815Q36818193-66B6BF8B-E3AC-4C08-ACA1-64AB1CA83446Q36897945-04B7170B-1885-4EC0-89A4-BD7E315D3A05Q36901827-F988D0A2-A48C-44DB-955A-6CB661F82AE1Q36955621-B2DE846B-DB93-47BC-A7B5-1392EEE970ACQ36957526-1312C7A2-3610-47C1-8F16-1949EBE82CDEQ37041726-D0F5A736-68B3-42A3-A4F9-C83D5721F29FQ37151565-8C8FAF5A-F8DC-414D-8354-E235A2F87F21Q37252134-038B19F2-2B9D-4A73-B3BE-E05855010771Q37312315-3B3B2EF1-7AEA-4F4F-BD82-01255B5CC2C4Q37327385-59A1EF21-1E36-43DA-A6F1-9090E7D3E48AQ37351215-49FE6577-ACED-49FF-BD37-98CA03779AAEQ37450106-C6B91E43-04C0-4B02-85E6-EAD255ABEBC7Q37586828-5C6CBFF1-390D-4140-814C-979A1DBCAFF9Q37728377-A8C69F02-CD9C-40E5-8F81-7713E614E1FAQ37729183-22E5FF3E-1C2C-4D58-995F-90F6A9CF14E2Q37769931-0C2A21D1-4E20-435C-BBB3-F10C9307D70D
P2860
Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Anti-anginal effect of fasudil ...... t angina: a multicenter study.
@en
Anti-anginal effect of fasudil ...... t angina: a multicenter study.
@nl
type
label
Anti-anginal effect of fasudil ...... t angina: a multicenter study.
@en
Anti-anginal effect of fasudil ...... t angina: a multicenter study.
@nl
prefLabel
Anti-anginal effect of fasudil ...... t angina: a multicenter study.
@en
Anti-anginal effect of fasudil ...... t angina: a multicenter study.
@nl
P2093
P1476
Anti-anginal effect of fasudil ...... t angina: a multicenter study.
@en
P2093
Hiroaki Shimokawa
Hirofumi Osada
Hiroshi Kishida
Hiroyuki Iinuma
Katsuhiko Hiramori
Kazunobu Yamauchi
Kazuzo Kato
Mitsuyoshi Nakashima
Saichi Hosoda
Takashi Katagiri
P304
P356
10.1097/00005344-200211000-00013
P407
P577
2002-11-01T00:00:00Z